Key stats
About GF CSI Medical ETF
Home page
Inception date
Sep 6, 2023
Structure
Open-Ended Fund
Replication method
Synthetic
Dividend treatment
Distributes
Primary advisor
GF Fund Management Co., Ltd.
ISIN
CNE1000067W3
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Stocks99.35%
Health Technology74.63%
Health Services14.10%
Process Industries5.83%
Distribution Services1.66%
Technology Services1.63%
Producer Manufacturing0.86%
Commercial Services0.35%
Consumer Non-Durables0.28%
Transportation0.00%
Bonds, Cash & Other0.65%
Cash0.65%
Miscellaneous0.00%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
560260 invests in stocks. The fund's major sectors are Health Technology, with 74.63% stocks, and Health Services, with 14.10% of the basket. The assets are mostly located in the Asia region.
560260 top holdings are Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A and WuXi AppTec Co., Ltd. Class A, occupying 10.50% and 9.99% of the portfolio correspondingly.
No, 560260 doesn't pay dividends to its holders.
560260 shares are issued by GF Securities Co., Ltd. under the brand GF Fund. The ETF was launched on Sep 6, 2023, and its management style is Passive.
560260 expense ratio is 0.55% meaning you'd have to pay 0.55% of your investment to help manage the fund.
560260 follows the CSI Medical Index Yield - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
560260 invests in stocks.